Two Sigma Investments, LP Merrimack Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

Shares

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	SELL	$13.06 - $15.0 $18,714 - $21,495	-1,433 Reduced 6.56%	20,401 $301,000
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $262,444 - $292,793	21,834 New	21,834 $292,000
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $77,173 - $262,347	20,971 Added 97.45%	42,490 $486,000
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $12,580 - $20,604	-3,400 Reduced 13.64%	21,519 $81,000
Q2 2022 Aug 15, 2022	SELL	$4.89 - $7.13 $28,459 - $41,496	-5,820 Reduced 18.93%	24,919 $148,000
Q1 2022 May 16, 2022	SELL	$3.75 - $6.82 $19,601 - $35,648	-5,227 Reduced 14.53%	30,739 $194,000
Q4 2021 Feb 14, 2022	SELL	$3.75 - $5.1 $37,308 - $50,739	-9,949 Reduced 21.67%	35,966 $141,000
Q3 2021 Nov 15, 2021	SELL	$4.3 - $6.39 $69,677 - $103,543	-16,204 Reduced 26.09%	45,915 $222,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $934,520 - $1.2 Million	-154,722 Reduced 71.35%	62,119 $397,000
Q1 2021 May 17, 2021	SELL	$6.15 - $8.7 $311,891 - $441,211	-50,714 Reduced 18.95%	216,841 $1.36 Million
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $987,277 - $2.22 Million	267,555 New	267,555 $1.84 Million
Q1 2020 May 15, 2020	SELL	$1.63 - $3.58 $30,503 - $66,996	-18,714 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $11,340 - $16,812	-3,600 Reduced 16.13%	18,714 $59,000
Q3 2019 Nov 14, 2019	SELL	$4.16 - $6.05 $2,912 - $4,235	-700 Reduced 3.04%	22,314 $100,000
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.66 $116,198 - $149,814	-26,469 Reduced 53.49%	23,014 $139,000
Q1 2019 May 15, 2019	SELL	$3.19 - $5.73 $74,626 - $134,047	-23,394 Reduced 32.1%	49,483 $344,000
Q4 2018 Feb 14, 2019	BUY	$2.95 - $4.15 $47,949 - $67,454	16,254 Added 28.71%	72,877 $281,000
Q3 2018 Nov 14, 2018	BUY	$3.91 - $4.66 $221,395 - $263,863	56,623 New	56,623 $302,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.